2023 November 14 | Business Today Qatar

You are here: Home » 2023 » November » Archives for 14th

ROSEN, LEADING INVESTOR COUNSEL, Encourages Capstone Green Energy Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CGRN, CGRNQ

NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capstone Green Energy Corp. (NASDAQ: CGRN) (OTC: CGRNQ) between June 14, 2021 and September 22, 2023, both dates inclusive (the "Class Period"), of the important December 12, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Capstone Green Energy securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Capstone Green Energy class action, go to https://rosenlegal.com/submit–form/?case_id=19761 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 12, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made materially false and/or misleading statements that: (1) Capstone had engaged in "bill and hold transactions" with customers; (2) these transactions were not reported pursuant to generally accepted accounting principles ("GAAP"); (3) "as a result of apparent errors primarily related to revenue recognition associated with bill and hold transactions" Capstone lacked a reasonable basis to report certain financial results and was reasonably likely to restate its financial statements; and (4) as a result of the foregoing, defendant's positive statements about Capstone's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Capstone Green Energy class action, go to https://rosenlegal.com/submit–form/?case_id=19761 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GLOBENEWSWIRE (Distribution ID 8979565)

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Barclays PLC Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BCS, BCLYF

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Barclays PLC (NYSE: BCS) (OTC: BCLYF) between July 22, 2019 and October 12, 2023, both dates inclusive (the "Class Period"), of the important January 2, 2024 lead plaintiff deadline in the securities class action commenced by the Firm.

SO WHAT: If you purchased Barclays securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Barclays class action, go to https://rosenlegal.com/submit–form/?case_id=19796 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 2, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period defendants made materially false and/or misleading statements and/or failed to disclose that: (1) contrary to false public assertions, Barclays's now–former group chief executive James "Jes" Staley ("Staley") had a very close relationship with Jeffrey Epstein ("Epstein"); (2) Staley was reportedly aware of Epstein's criminal activities and may have even sexually assaulted a victim who had previously been trafficked by Epstein; (3) Staley's close, personal relationship with Epstein, and potential criminal activity, if discovered, could bring reputational, legal, and financial harm to Barclays; (4) as a result, Barclays's response to the British Financial Conduct Authority's ("FCA") inquiry regarding Staley's relationship with Epstein was materially false; (5) Barclays, having become aware of information contradicting its response to the FCA's inquiry, then failed to update the response so that it would be accurate, or otherwise take any meaningful action; and (6) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Barclays class action, go to https://rosenlegal.com/submit–form/?case_id=19796 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm's attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40^th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GLOBENEWSWIRE (Distribution ID 8979524)

ROSEN, A RESPECTED AND LEADING FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BCLI

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the "Class Period"), of the important January 2, 2024 lead plaintiff deadline. in the securities class action commenced by the Firm.

SO WHAT: If you purchased Brainstorm Cell securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Brainstorm Cell class action, go to https://rosenlegal.com/submit–form/?case_id=19375 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 2, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Brainstorm Cell downplayed the severity of the U.S. Food and Drug Administration's ("FDA") refusal to file letter; (2) Brainstorm Cell continued to conceal the risks associated with the submission of the biologics license application ("BLA"); and (3) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Brainstorm Cell class action, go to https://rosenlegal.com/submit–form/?case_id=19375 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

GLOBENEWSWIRE (Distribution ID 8979521)

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Advance Auto Parts, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AAP

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Advance Auto Parts, Inc. (NYSE: AAP) between November 16, 2022 and May 30, 2023, both dates inclusive (the "Class Period"), of the important December 8, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Advance Auto securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Advance Auto class action, go to https://rosenlegal.com/submit–form/?case_id=19738 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 8, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

DETAILS OF THE CASE: According to the lawsuit, defendants made materially false and/or misleading statements that: (1) misrepresented the efficacy of Advance Auto's strategic pricing initiative and the impact of price reductions; (2) omitted and/or concealed the negative impacts of the pricing initiative; (3) provided investors with an overly optimistic perception of Advance Auto's operations; and (4) created the false impression that inflation and macroeconomic factors had an insubstantial impact on Advance Auto's margins. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Advance Auto class action, go to https://rosenlegal.com/submit–form/?case_id=19738 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

GLOBENEWSWIRE (Distribution ID 8979466)

ROSEN, LEADING INVESTOR COUNSEL, Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AHCO

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4, 2020 and February 27, 2023, both dates inclusive (the "Class Period") or (2) AdaptHealth common stock pursuant and/or traceable to the Company's secondary public offering (the "SPO") conducted on or around January 5, 2021, of the important December 26, 2023 lead plaintiff deadline.

SO WHAT: If you purchased AdaptHealth common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the AdaptHealth class action, go to https://rosenlegal.com/submit–form/?case_id=20167 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 26, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements because: (1) AdaptHealth misstated the Company's true ability to generate organic growth in its diabetes segment; (2) AdaptHealth engaged in improper upcoding and other illicit billing practices; (3) that, as a result of the foregoing, certain of the defendants' statements about the Company's business, operations and prospects were materially misleading and/or lacked a reasonable basis.

Further, the lawsuit alleges the "SPO Offering Materials contained untrue statements of material fact, omitted material facts necessary to make the statements contained therein not misleading, and failed to make adequate disclosures required under the rules and regulations governing the preparation of such documents." When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the AdaptHealth class action, go to https://rosenlegal.com/submit–form/?case_id=20167 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

GLOBENEWSWIRE (Distribution ID 8979426)

Ma'aden com um papel fundamental na abordagem dos desafios do setor, no Future Minerals Forum 2024

RIADE, Arábia Saudita, Nov. 14, 2023 (GLOBE NEWSWIRE) — O Future Minerals Forum (FMF) anunciou hoje que a Ma'aden ir regressar como Parceira Fundadora do evento pelo terceiro ano consecutivo. A Ma'aden, a maior empresa de recursos naturais multi–commodities do Mdio Oriente, voltar a desempenhar um papel central nos debates que moldam o setor global dos minerais durante o FMF 2024, em janeiro.

Este evento centrar–se– na criao de cadeias de valor mineral resilientes e responsveis na super–regio de frica, sia Ocidental e Central, rica em recursos minerais. O FMF 2024 ir reunir lderes governamentais, executivos do setor mineiro, investidores e outras partes interessadas para impulsionar a parceria e o crescimento, contribuindo para um setor sustentvel e reforando as cadeias de abastecimento de minerais a nvel mundial.

No FMF do ano passado, a Ma'aden fez uma srie de anncios significativos, incluindo o de uma importante joint–venture com o PIF, a Manara Minerals, que apoia as cadeias de abastecimento de minerais a nvel mundial, as quais so essenciais para a transio energtica. A Ma'aden anunciou igualmente acordos de destaque com os lderes mineiros mundiais Ivanhoe Electric e Barrick Gold Corporation, que contribuem para impulsionar o desenvolvimento do setor mineiro do Reino.

O Frum desempenha um papel fundamental no apoio ao investimento e s parcerias, na Arbia Saudita e a nvel mundial.

As novas e excitantes iniciativas que sero discutidas no FMF 2024 incluem o aumento da capacidade dos recursos humanos e do talento na regio atravs de centros de excelncia; o desenvolvimento de normas de sustentabilidade que satisfaam os requisitos dos pases anfitries e mantenham a confiana da sociedade; e a criao de um centro de metais verdes na super–regio atravs da utilizao de tecnologias modernas e do desenvolvimento de centros de processamento.

O FMF 2023 foi um sucesso retumbante, com mais de 9000 participantes presenciais e mais de 13 000 participantes remotos. Espera–se que o FMF 2024 tenha um alcance ainda mais alargado, centrando–se em solues prticas para os desafios que o setor mineiro e mineral enfrenta.

O FMF 2024 realizar–se– sob o patrocnio do Guardio das Duas Mesquitas Sagradas, o Rei Salman bin Abdulaziz Al Saud, no Centro Internacional de Convenes Rei Abdulaziz, em Riade, de 9 a 11 de janeiro de 2024.

Para saber mais sobre o FMF 2024 e para se inscrever no evento, visite https://www.futuremineralsforum.com/registration/.

GLOBENEWSWIRE (Distribution ID 1000899402)

Future Minerals Forum 2024: Ma'aden spielt Schlüsselrolle bei der Bewältigung der Herausforderungen in der Mineralindustrie

RIAD, Saudi–Arabien, Nov. 14, 2023 (GLOBE NEWSWIRE) — Das Future Minerals Forum (FMF) gab heute bekannt, dass Ma'aden bereits zum dritten Jahr in Folge als Grndungspartner an der Veranstaltung teilnehmen wird. Als grtes Rohstoffunternehmen im Nahen Osten wird Ma'aden im Rahmen des FMF 2024 im Januar erneut eine entscheidende Rolle in den Diskussionen um die Gestaltung des globalen Mineraliensektors spielen.

Im Mittelpunkt der Veranstaltung steht die Schaffung krisensicherer und verantwortungsvoller Wertschpfungsketten in der rohstoffreichen Superregion Afrika, West– und Zentralasien. Das FMF 2024 wird Regierungsvertreter, Fhrungskrfte aus dem Bergbausektor, Investoren und andere Stakeholder zusammenbringen. Ziel ist es, Partnerschaften und Wachstum zu frdern, die zur Nachhaltigkeit des Sektors beitragen und die globalen Lieferketten fr Mineralien strken.

Im vergangenen Jahr gab Ma'aden auf dem FMF eine Reihe wichtiger Ankndigungen bekannt, darunter ein bedeutendes Joint Venture mit dem PIF namens Manara Minerals. Das Unternehmen soll die Entwicklung stabiler globaler Lieferketten untersttzen, die fr die Energiewende von entscheidender Bedeutung sind. Ma'aden hat auch wichtige Vereinbarungen mit den weltweit fhrenden Bergbauunternehmen Ivanhoe Electric und Barrick Gold Corporation abgeschlossen, um die Entwicklung des Bergbausektors im Knigreich voranzutreiben.

Das Forum spielt eine wichtige Rolle bei der Frderung von Investitionen und Partnerschaften in Saudi–Arabien und weltweit.

Spannende neue Initiativen, die auf dem FMF 2024 diskutiert werden, umfassen die Entwicklung von Humanressourcen und Talenten in der Region mithilfe von Kompetenzzentren; die Schaffung von Nachhaltigkeitsstandards, die den Anforderungen der Gastlnder entsprechen und das Vertrauen der Gesellschaft gewinnen; sowie die Errichtung einer Drehscheibe fr nachhaltige Metalle in der Superregion, die durch den Einsatz moderner Technologien und die Einrichtung von Verarbeitungszentren mglich gemacht werden soll.

Das FMF 2023 war mit ber 9.000 Teilnehmern vor Ort und ber 13.000 Teilnehmern aus der Ferne ein durchschlagender Erfolg. Das FMF 2024 wird voraussichtlich eine noch grere Reichweite haben und den Fokus auf umsetzbare Lsungen fr die Herausforderungen des Bergbau– und Mineraliensektors legen.

Das FMF 2024 findet vom 9. bis 11. Januar 2024 im King Abdulaziz International Convention Center in Riad statt und steht unter der Schirmherrschaft des Kustos der beiden Heiligen Moscheen, Knig Salman bin Abdulaziz Al Saud.

Weitere Informationen ber das FMF 2024 und die Mglichkeit zur Anmeldung finden Sie unter https://www.futuremineralsforum.com/registration/.

GLOBENEWSWIRE (Distribution ID 1000899402)

Édition 2024 du Forum sur les Minéraux du Futur : Ma’aden jouera un rôle clé dans les débats relatifs aux enjeux de l’industrie minière

RIYAD, Arabie Saoudite, 14 nov. 2023 (GLOBE NEWSWIRE) — Le Forum sur les Minraux du Futur (ci–aprs FMF ) a annonc aujourd'hui que Ma'aden serait nouveau et pour la troisime anne de suite partenaire fondateur de l'vnement. Ma'aden, la plus importante socit d'exploitation des ressources naturelles pour produits divers du Moyen–Orient, jouera nouveau un rle cl dans les dbats visant faonner l'industrie minire internationale l'occasion de l'dition 2024 du FMF en janvier prochain.

Cet vnement sera ddi la cration de chanes de valeur minires rsilientes et responsables dans la super rgion riche en ressources minrales qui s'tend de l'Afrique l'Asie occidentale et centrale. Le FMF 2024 runira des chefs de gouvernement, des dirigeants de compagnies minires, des investisseurs et d'autres parties prenantes dans le but de stimuler la fois les partenariats et la croissance pour l'avnement d'un secteur durable et la consolidation des chanes d'approvisionnement mondiales en minerais.

L'anne dernire, Ma'aden avait annonc lors du FMF une srie de nouvelles importantes, et notamment la cration d'une coentreprise de vaste envergure avec PIF et Manara Minerals pour appuyer les chanes d'approvisionnement mondiales en minerais essentielles la transition nergtique. Ma'aden avait galement annonc la passation d'accords de taille avec les gants de l'industrie minire internationale, savoir Ivanhoe Electric et Barrick Gold Corporation, accompagnant ainsi le dveloppement du secteur minier du royaume saoudien.

Le Forum joue un rle majeur dans le soutien aux investissements et aux partenariats, en Arabie Saoudite et dans le monde entier.

Les nouvelles initiatives passionnantes qui feront l'objet de dbats lors du FMF 2024 comprennent notamment l'augmentation de la capacit des ressources humaines et des talents dans la rgion grce des centres ducatifs, l'laboration de normes de durabilit conformes aux exigences des pays htes et permettant d'entretenir la confiance de la population, ou encore la cration rgionale d'un ple de mtaux verts au moyen de technologies modernes, et le dveloppement de centres de traitement.

Le FMF a connu un succs retentissant en 2023, rassemblant plus de 9 000 visiteurs sur site et plus de 13 000 participants en ligne. Axe sur des solutions de rponse concrtes aux enjeux de l'industrie minire, l'dition 2024 devrait conqurir un auditoire encore plus large.

Cette nouvelle dition du FMF, sous mcnat du Gardien des deux Saintes Mosques, Sa Majest le Roi Salman ben Abdelaziz d'Arabie Saoudite, se tiendra Riyad du 9 au 11 janvier 2024, au Centre international de confrences du Roi Abdelaziz.

Pour en savoir plus sur le FMF 2024 et vous inscrire l'vnement, veuillez consulter le site https://www.futuremineralsforum.com/registration/.

GLOBENEWSWIRE (Distribution ID 1000899402)

Movellus Introduces Aeonic Insight™ Product Line for On-die Telemetry

SUNNYVALE, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Movellus today announced the introduction of the Aeonic Insight product family aimed at meeting the rapidly evolving needs for on–die observability in complex SoCs. The Aeonic Insight product family delivers industry–leading synthesizable sensors that provide actionable silicon insights. These sensors are area–efficient and process–portable, generating advanced telemetry for SoC management and silicon lifecycle analytics platforms.

The first product in this family is the Aeonic Insight Droop Detector. This innovative solution enables fine–grained droop detection with multiple thresholds and is amongst the fastest in detection time. The Aeonic Insight observability philosophy also extends to the Aeonic Generate CGM, which introduces detailed clock health telemetry to our industry–leading synthesizable clock generation portfolio.

“The rise of large SoCs introduces new silicon design challenges around balancing performance, power and yield, and optimizing silicon health over its lifecycle,” said Vikram Karvat, SVP Products, Marketing, and Planning. “Movellus is able to generate advanced on–die telemetry to aid our customers and partners in delivering products with the highest quality, performance, and longevity for advanced applications.”

Movellus continues to advance high–performance silicon through feature–rich, synthesizable IP. The Aeonic Digital IP platform has been integrated by multiple customers across various process nodes, from 40nm to 3nm. End applications range from ultra–low power edge AI devices to performance–centric cloud datacenter compute and AI offerings. This latest milestone enables advanced on–die observability to cutting–edge SoCs, AI accelerators, and processors.

About Movellus
Movellus provides critical technology that is integrated into an array of applications ranging from edge AI devices to performance–centric cloud datacenter compute and networking offerings. The company is headquartered in Sunnyvale, CA, with R&D centers in Michigan and Toronto. Visit us at: www.movellus.com

Movellus, the Movellus logo, Aeonic, Aeonic Generate, Elevating Silicon, Aeonic Insight, and Intelligent Clock Networks are among the trademarks of Movellus. The term “Movellus” refers to Movellus Circuits, Inc and/or its subsidiaries. Other trademarks are the property of their respective owners.

Press Contact
Aakash Jani
aakash@movellus.com
+1–503–545–6320

GLOBENEWSWIRE (Distribution ID 8977714)

Know how to manage and prevent diabetes for a better life

BRUSSELS, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) — The International Sweeteners Association (ISA) proudly renews its support to World Diabetes Day (WDD), organised each year on 14th November by the International Diabetes Federation (IDF) and in 2023 with the theme "Know your risk, know your response'.¹

1 in 10 adults worldwide, approximately 537 million people, have diabetes and half a billion more are at risk of developing type 2 diabetes.² Though, type 2 diabetes and its complications can be delayed or prevented by adopting and maintaining healthy habits, including following a balanced diet and being physically active. This is why the ISA joins the call to help increase awareness of diabetes risk and response.

Discover the latest nutritional guidelines for diabetes management
Knowing your risk of type 2 diabetes to help delay or prevent the condition is important. Knowing what to do and eat for better diabetes control is also vital! The ISA supports health professionals in staying informed of the latest evidence–based nutritional guidelines to inform discussions with patients on diabetes prevention and management. Hence, the ISA online campaign for World Diabetes Day 2023 aims to raise awareness about the importance of knowing what to eat for diabetes prevention and management, while sharing the latest nutritional guidelines for diabetes management and the recommendations for the intake of low/no calorie sweeteners in diabetes:

Watch the ISA video presenting recent clinical practice and nutritional guidelines for diabetes management, including about low/no calorie sweeteners
Download the new ISA factsheet for healthcare professionals on low/no calorie sweeteners in diabetes
Discover chapter 5 of the ISA booklet dedicated to "Low/no calorie sweeteners, diabetes and cardiometabolic health"
Join the ISA webinar organised together with the Brazilian Society for Food and Nutrition (Sociedade Brasileira de Alimentao e Nutrio – SBAN) on 1st December 2023 on the theme "Recommendations and regulation on the use of low/no calorie sweeteners: Global and Brazilian perspectives" (more information to be available soon).

Low/no calorie sweeteners as part of healthy diet for people with diabetes
Alongside other cornerstones of diabetes management, a healthy diet has the potential to improve glucose control, reduce the risk of diabetes complications and improve quality of life. Diabetes and nutrition–related organisations globally recognise that low/no calorie sweeteners can be safely used by people with diabetes to help reduce overall energy and sugars intake without affecting blood glucose control, and thus be a helpful strategy to aid with glycaemic control and weight management.^3–8 This was recognised, among others, in the "Evidence–based European recommendations for the dietary management of diabetes" updated in April 2023 by the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD)³ and by the American Diabetes Association (ADA) in their annually updated “Standards of Care in Diabetes” including the ADA's current clinical practice and medical nutrition therapy recommendations.⁴

ISA activities for World Diabetes Day 2023 have been endorsed by diabetes organisations including the Brazilian diabetes association (ANAD)⁹, the Brazilian Association of Diabetes Educators (ANBED)¹⁰ and the Brazilian Federation of Diabetes Organisations (FENAD).¹¹

Share the ISA campaign for World Diabetes Day 2023 on social media with your friends, family and network by using the dedicated hashtags #ISA4WDD, #WorldDiabetesDay and #KnowYourRisk.

More information about ISA activities for World Diabetes Day is available here.

REFERENCES:

More information about World Diabetes Day 2023 is available on the WDD website available at: https://worlddiabetesday.org
IDF, Diabetes Atlas 10th edition 2021. Available at: https://diabetesatlas.org/atlas/tenth–edition/ (Accessed 20 October 2023)
Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence–based European recommendations for the dietary management of diabetes. Diabetologia. 2023 Jun;66(6):965–985. https://doi.org/10.1007/s00125–023–05894–8
ElSayed NA, Aleppo G, Aroda VR, et al, on behalf of the American Diabetes Association. 5. Facilitating Positive Health Behaviors and Well–being to Improve Health Outcomes: Standards of Care in Diabetes–2023. Diabetes Care. 2023 Jan 1;46(Supple 1):S68–S96. https://doi.org/10.2337/dc23–S005
Diabetes UK. The use of low or no calorie sweeteners. Position Statement (Updated December 2018). Available at: https://www.diabetes.org.uk/professionals/position–statements–reports/food–nutrition–lifestyle/use–of–low–or–no–calorie–sweetners (Accessed 20 October 2023)
Laviada–Molina H, Escobar–Duque ID, Pereyra E, et al. Consenso de la Asociacin Latinoamericana de Diabetes sobre uso de edulcorantes no calricos en personas con diabetes [Consensus of the Latin–American Association of Diabetes on low calorie sweeteners in persons with diabetes]. Rev ALAD. 2018;8:152–74.
Sievenpiper JL, Chan CB, Dworatzek PD, Freeze C, Williams SL. Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Nutrition Therapy. Can J Diabetes. 2018;42(Suppl 1):S64–S79
MacLeod J, Franz MJ, Handu D, et al. Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Nutrition Intervention Evidence Reviews and Recommendations. J Acad Nutr Diet. 2017;117(10):1637–1658
Associao Nacional de Ateno ao Diabetes
Associao Nacional Brasileira de Educadores em Diabetes
Federao Nacional de Associaes e Entitades de Diabetes

ISA – Avenue de Tervueren 13A "" Bte 7, B–1040 Brussels, Belgium – Tel: +32 (0)2 736 53 54 – Fax: +32 (0)2 732 34 27
E–mail: info@sweeteners.org – Website: www.sweeteners.org – TVA BE 424.301.259

GLOBENEWSWIRE (Distribution ID 8979273)

November 2023
M	T	W	T	F	S	S
« Oct				Dec »
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30